The Memorial Sloan Kettering Cancer Center (MSK) in New York, one of the most prestigious and respected centers worldwide for its relentless pursuit of a cure for cancer, has recognized the work of Dr. Braulio Valdebenito, a prominent Chilean scientist and bioinformatics engineer. Valdebenito, a graduate of the University of Talca, has been awarded for his groundbreaking research on gastric cancer, one of the most devastating diseases globally.
Valdebenito’s work focuses on the use of computational modeling to study the evolution of normal and precancerous cells into malignant tumors. His goal is to identify early biomarkers that could predict the development of cancer, which could revolutionize the detection and treatment of this disease. This achievement represents a significant advancement in the fight against cancer, an area in which MSK has been a pioneer for over 30 years.
This recognition not only highlights the quality of research conducted in Chile but also reinforces the importance of international collaboration in the search for innovative solutions to combat cancer.